Navigation Links
Pop-On Male External Catheters

ProductsPop-On Male External Catheters
Company Rochester Medical
Item Pop-On Male External Catheters
Features 
  • This breathable, soft catheter is latex-free, reducing the potential for skin irritation
  • The clear silicone permits a visual inspection of the skin without removing the catheter
  • The Pop-On catheter is available in five diameter sizes to provide a proper fit that ensures superior patient comfort and greater reliability
Description The Pop-On® all silicone self-adhesive male external catheter is specially designed for the special needs of men. The unique 1.5-inch sheath with a forward-placement adhesive band will work for men with a short or retracted penis. It may also be preferred when a longer sheath is not desired or when users may benefit from a different adhesive location on their skin. The Pop-On catheter is shorter without a reduction in adhesive area.
Info Rochester Medical
Customer Service: (800) 243-3315
Web site: http://www.rocm.com/

Related medicine products :

1. The External Neurological Drainage System
2. Monitorr ICP External CSF Drainage and Monitoring System
3. Monitorr ICP External CSF Drainage System
4. EDS 3 CSF External Drainage System
5. Lumbar External Drainage System (LED)
6. External Ventricular Drainage (EVD)
7. Becker External Drainage and Monitoring System
8. Dual-Chamber Model 5388 External (Temporary) Pulse Generator
9. Single-Chamber Model 5348 External (Temporary) Pulse Generator
10. The Hoffmann® II For External Fixation
11. XCaliber External Fixator
Breaking Medicine News(10 mins):Health News:Centegra Expands H1N1 Vaccines to General Public 2Health News:Centegra Expands H1N1 Vaccines to General Public 3Health News:Centegra Expands H1N1 Vaccines to General Public 4Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 2Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 3Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 4Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 5Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 6Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 7Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 8Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 9Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 10Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 11Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 12Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 13Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 14Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 15Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 16Health News:PeopleStreme Human Capital Releases 'New Trends in Performance Management - 2010' Whitepaper 2Health News:Jackson & Coker Ranks #3 among “Ten Best Staffing Firms to Work For” 2Health News:Jackson & Coker Ranks #3 among “Ten Best Staffing Firms to Work For” 3Health News:Jackson & Coker Ranks #3 among “Ten Best Staffing Firms to Work For” 4Health News:Approval of Michigan Smoke-Free Legislation is Historic Win for Health 2Health News:Approval of Michigan Smoke-Free Legislation is Historic Win for Health 3
Other Medicine News:Health News:DiagnoCure's GCC marker for the staging of colorectal cancer discussed at the Eastern Cooperative Oncology Group 2Health News:DiagnoCure's GCC marker for the staging of colorectal cancer discussed at the Eastern Cooperative Oncology Group 3Health News:SXC Health Solutions announces informedRx renewal contract with The University of Michigan 2Health News:Samplify Systems Announces Distribution Agreement With Tokyo Electron Device Limited, Broadening Availability of Signal Compression Technology 2Health News:Breastfeeding.com Launches First Ever Social Network for Birth-Related Medical Professionals 2Health News:Womenshealthchannel Enhancements Support Pregnant Teens 2Health News:Womenshealthchannel Enhancements Support Pregnant Teens 3Health News:Womenshealthchannel Enhancements Support Pregnant Teens 4Health News:Womenshealthchannel Enhancements Support Pregnant Teens 5Health News:Breakthrough "Neuro Nutrition" Targets the Brain and Vagus Nerve To Boost the Body's Immune, Hormone and Neurological Systems 2Health News:Breakthrough "Neuro Nutrition" Targets the Brain and Vagus Nerve To Boost the Body's Immune, Hormone and Neurological Systems 3Health News:Breakthrough "Neuro Nutrition" Targets the Brain and Vagus Nerve To Boost the Body's Immune, Hormone and Neurological Systems 4Health News:Breakthrough "Neuro Nutrition" Targets the Brain and Vagus Nerve To Boost the Body's Immune, Hormone and Neurological Systems 5
Breaking Medicine Technology:Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 2Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 3Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 2Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 3Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 4Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 5Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 6Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 7Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 8Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 9Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 10China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010 2China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010 3New Evidence Supports HPV Vaccine 50832 1New Evidence Supports HPV Vaccine 50832 2Pelosi Remarks on Economic Recovery Act at Mission Neighborhood Health Center in San Francisco 50830 1Pelosi Remarks on Economic Recovery Act at Mission Neighborhood Health Center in San Francisco 50830 2Carbohydrate acts as tumor suppressor 50828 1Carbohydrate acts as tumor suppressor 50828 2